MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.253
-0.012 (-0.92%)
Nov 21, 2024, 3:09 PM EST - Market open
MIRA Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -11.24 | -11.98 | -7.06 | -2.18 | -0.2 |
| Other Amortization | - | 0.73 | - | - | - |
| Stock-Based Compensation | 1.59 | 2.55 | 1.3 | - | - |
| Other Operating Activities | 3.73 | 3.71 | 0.01 | 0.02 | - |
| Change in Accounts Receivable | -0.01 | -0.01 | - | - | - |
| Change in Accounts Payable | -0.09 | -0.39 | 0.15 | 0.78 | - |
| Change in Other Net Operating Assets | 1.23 | 0.86 | -0.01 | - | - |
| Operating Cash Flow | -4.79 | -4.53 | -5.6 | -1.38 | -0.2 |
| Short-Term Debt Issued | - | 2.15 | - | 0.2 | - |
| Total Debt Issued | 2.15 | 2.15 | - | 0.2 | 0.27 |
| Short-Term Debt Repaid | - | -1.14 | -0.16 | - | - |
| Total Debt Repaid | -1.02 | -1.14 | -0.16 | - | - |
| Net Debt Issued (Repaid) | 1.12 | 1.01 | -0.16 | 0.2 | 0.27 |
| Issuance of Common Stock | 1.78 | 7.7 | 2.9 | 4.51 | - |
| Other Financing Activities | 0.16 | 0.07 | 0.4 | -0.53 | -0.06 |
| Financing Cash Flow | 3.07 | 8.78 | 3.15 | 4.18 | 0.21 |
| Net Cash Flow | -1.72 | 4.25 | -2.46 | 2.81 | 0.01 |
| Free Cash Flow | -4.79 | -4.53 | -5.6 | -1.38 | -0.2 |
| Free Cash Flow Per Share | -0.24 | -0.24 | -0.32 | -0.11 | - |
| Levered Free Cash Flow | -4.46 | -4.73 | -3 | -0.66 | - |
| Unlevered Free Cash Flow | -2.83 | -3.3 | -2.99 | -0.64 | - |
| Change in Net Working Capital | -0.02 | 0.52 | -0.12 | -0.7 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.